Moderators and mediators of a digital cognitive behavior therapy-guided self-help intervention for eating disorders: Informing future design efforts.


Journal

Journal of consulting and clinical psychology
ISSN: 1939-2117
Titre abrégé: J Consult Clin Psychol
Pays: United States
ID NLM: 0136553

Informations de publication

Date de publication:
May 2023
Historique:
pmc-release: 01 05 2024
medline: 22 5 2023
pubmed: 13 1 2023
entrez: 12 1 2023
Statut: ppublish

Résumé

The Student Bodies-Eating Disorders intervention (SB-ED), a digital cognitive behavior therapy-guided self-help intervention for college women with an eating disorder, is effective for reducing eating disorder psychopathology. The purpose of this study was to evaluate moderators and mediators of the SB-ED intervention. To our knowledge, this is the first evaluation of clinical mediators of a digital intervention for women with eating disorders. This is an exploratory secondary analysis of a cluster randomized trial comparing the SB-ED intervention to referral to usual care among 690 women at 27 United States colleges. Moderators included body mass index (BMI), race, ethnicity, weight/shape concerns, eating disorder impairment, thin ideal internalization, depression, anxiety, and motivation for treatment, assessed at baseline. Thin ideal internalization and depressive symptoms were tested as predictors at postintervention and mediators at 2-year follow-up. Outcome was change in global eating disorder psychopathology. BMI moderated the effect of the intervention at follow-up (but not posttreatment), with individuals with a lower BMI experiencing more continued improvements in eating disorder psychopathology following the intervention than individuals with a higher BMI. Thin ideal internalization mediated the effect of the intervention at follow-up, and depression partially mediated the effect of the intervention at follow-up. Results of the mediator analyses suggest that helping college women reduce inflated internalization of the thin ideal and improve depressive symptoms leads to improvements in eating disorder psychopathology. Results also suggest opportunities to optimize the intervention so individuals across the BMI spectrum experience ongoing improvements over time. (PsycInfo Database Record (c) 2023 APA, all rights reserved).

Identifiants

pubmed: 36634022
pii: 2023-37115-001
doi: 10.1037/ccp0000786
pmc: PMC10198808
mid: NIHMS1864934
doi:

Banques de données

ClinicalTrials.gov
['NCT02076464']

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

280-284

Subventions

Organisme : NIDDK NIH HHS
ID : K23 DK114480
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007456
Pays : United States
Organisme : NIMH NIH HHS
ID : K08 MH120341
Pays : United States
Organisme : NIMHD NIH HHS
ID : F31 MD015679
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH100455
Pays : United States
Organisme : NIDDK NIH HHS
ID : K01 DK120778
Pays : United States
Organisme : NIDDK NIH HHS
ID : K01 DK116925
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL130357
Pays : United States

Références

J Consult Clin Psychol. 2002 Apr;70(2):267-74
pubmed: 11952185
Arch Gen Psychiatry. 2002 Oct;59(10):877-83
pubmed: 12365874
Int J Eat Disord. 1994 Nov;16(3):227-38
pubmed: 7833956
J Abnorm Psychol. 2017 Jan;126(1):38-51
pubmed: 27709979
JAMA Netw Open. 2020 Aug 3;3(8):e2015633
pubmed: 32865576
J Am Coll Health. 2011;59(8):700-7
pubmed: 21950250
J Consult Clin Psychol. 2016 May;84(5):402-14
pubmed: 26795936
Eur Eat Disord Rev. 2017 Jan;25(1):3-12
pubmed: 27862611
Assessment. 2011 Sep;18(3):263-83
pubmed: 21697139
Arch Gen Psychiatry. 2006 Aug;63(8):881-8
pubmed: 16894064
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Clin Psychol Rev. 2021 Feb;83:101953
pubmed: 33422841
Int J Eat Disord. 2017 Mar;50(3):170-189
pubmed: 28102908
Int J Eat Disord. 2013 Jul;46(5):529-32
pubmed: 23658106
Body Image. 2022 Mar;40:103-109
pubmed: 34896896
Int J Eat Disord. 2019 Oct;52(10):1125-1136
pubmed: 31268183
JAMA. 2016 Jun 7;315(21):2284-91
pubmed: 27272580
Arch Gen Psychiatry. 2002 Aug;59(8):713-21
pubmed: 12150647
Am J Psychiatry. 2006 Jul;163(7 Suppl):4-54
pubmed: 16925191
J Am Coll Health. 2019 May-Jun;67(4):357-366
pubmed: 29979922
Psychol Med. 2011 Sep;41(9):1939-49
pubmed: 21276276
J Consult Clin Psychol. 2011 Jun;79(3):398-405
pubmed: 21500884

Auteurs

Andrea K Graham (AK)

Center for Behavioral Intervention Technologies, Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine.

Ellen E Fitzsimmons-Craft (EE)

Department of Psychiatry, Washington University School of Medicine.

Shiri Sadeh-Sharvit (S)

Center for m2Health, Palo Alto University.

Katherine N Balantekin (KN)

Department of Exercise and Nutrition Sciences, University at Buffalo.

Dawn M Eichen (DM)

Department of Pediatrics, University of California.

Marie-Laure Firebaugh (ML)

Department of Psychiatry, Washington University School of Medicine.

Neha J Goel (NJ)

Department of Psychology, Virginia Commonwealth University.

Grace E Monterubio (GE)

Department of Psychiatry, Washington University School of Medicine.

Anna M Karam (AM)

Department of Psychiatry, Washington University School of Medicine.

Rachael E Flatt (RE)

Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill.

Booil Jo (B)

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine.

Corinna Jacobi (C)

Institute of Clinical Psychology and Psychotherapy, Technische Universitat Dresden.

Denise E Wilfley (DE)

Department of Psychiatry, Washington University School of Medicine.

C Barr Taylor (CB)

Center for m2Health, Palo Alto University.

Mickey Trockel (M)

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH